10.91MMarket Cap-0.69P/E (TTM)
1.8200High1.6000Low244.90KVolume1.6000Open1.6250Pre Close425.57KTurnover4.52%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High4.40P/B9.70MFloat Cap1.290052wk Low--Dividend TTM5.42MShs Float1419.0000Historical High--Div YieldTTM13.54%Amplitude1.2900Historical Low1.7370Avg Price1Lot Size
Can-Fite BioPharma Stock Forum
$Can-Fite BioPharma (CANF.US)$
with multiple analysts putting target at $10 this is still very much flying under the radar.. good time to scoop a bargain 😉
Can-Fite's Namodenoson Shows Groundbreaking 8-Year Cancer-Free Result in Liver Cancer Patient
Can-Fite Biopharma Has Received A Notice Of Allowance For A US Patent Titled "AN A3 ADENOSINE RECEPTOR LIGAND FOR USE FOR ACHIEVING A FAT LOSS EFFECT (FOR THE TREATMENT OF OBESITY)"
No comment yet